149 related articles for article (PubMed ID: 35714570)
1. TSC22D4 promotes TGFβ1-induced activation of hepatic stellate cells.
Sakurai M; Weber P; Wolff G; Wieder A; Szendroedi J; Herzig S; Ekim Üstünel B
Biochem Biophys Res Commun; 2022 Aug; 618():46-53. PubMed ID: 35714570
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function.
Wolff G; Sakurai M; Mhamane A; Troullinaki M; Maida A; Deligiannis IK; Yin K; Weber P; Morgenstern J; Wieder A; Kwon Y; Sekar R; Zeigerer A; Roden M; Blüher M; Volk N; Poth T; Hackert T; Wiedmann L; De Angelis Rigotti F; Rodriguez-Vita J; Fischer A; Mukthavaram R; Limphong P; Tachikawa K; Karmali P; Payne J; Chivukula P; Ekim-Üstünel B; Martinez-Jimenez CP; Szendrödi J; Nawroth P; Herzig S
Mol Metab; 2022 Jun; 60():101487. PubMed ID: 35378329
[TBL] [Abstract][Full Text] [Related]
3. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
Kimura T; Singh S; Tanaka N; Umemura T
Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease.
Romualdo GR; Da Silva TC; de Albuquerque Landi MF; Morais JÁ; Barbisan LF; Vinken M; Oliveira CP; Cogliati B
Environ Toxicol; 2021 Feb; 36(2):168-176. PubMed ID: 32918399
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis.
Okina Y; Sato-Matsubara M; Matsubara T; Daikoku A; Longato L; Rombouts K; Thanh Thuy LT; Ichikawa H; Minamiyama Y; Kadota M; Fujii H; Enomoto M; Ikeda K; Yoshizato K; Pinzani M; Kawada N
J Hepatol; 2020 Oct; 73(4):882-895. PubMed ID: 32330605
[TBL] [Abstract][Full Text] [Related]
7. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
9. Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation.
Nagasaki A; Sakamoto S; Chea C; Ishida E; Furusho H; Fujii M; Takata T; Miyauchi M
Sci Rep; 2020 Mar; 10(1):4134. PubMed ID: 32139740
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice.
Chung KJ; Legaki AI; Papadopoulos G; Gercken B; Gebler J; Schwabe RF; Chavakis T; Chatzigeorgiou A
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902241
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
[TBL] [Abstract][Full Text] [Related]
12. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
[TBL] [Abstract][Full Text] [Related]
13. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
Ni XX; Li XY; Wang Q; Hua J
J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
[TBL] [Abstract][Full Text] [Related]
14. Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells.
Kiagiadaki F; Kampa M; Voumvouraki A; Castanas E; Kouroumalis E; Notas G
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):891-899. PubMed ID: 29287776
[TBL] [Abstract][Full Text] [Related]
15. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
16. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
[TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.
Yang A; Yan X; Fan X; Shi Y; Huang T; Li W; Chen W; Jia J; You H
Hepatol Int; 2021 Oct; 15(5):1122-1135. PubMed ID: 34014450
[TBL] [Abstract][Full Text] [Related]
18. Novel Interplay Between Sonic Hedgehog and Transforming Growth Factor-β1 in Human Nonalcoholic Steatohepatitis.
Zhou X; Wang P; Ma Z; Li M; Teng X; Sun L; Wan G; Li Y; Guo L; Liu H
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):154-160. PubMed ID: 32044884
[TBL] [Abstract][Full Text] [Related]
19. Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis.
He L; Yuan H; Liang J; Hong J; Qu C
PLoS One; 2020; 15(5):e0233702. PubMed ID: 32442221
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]